[HTML][HTML] Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination
C Antonio-Nkondjio, C Ndo, F Njiokou, JD Bigoga… - Parasites & vectors, 2019 - Springer
Malaria still has a devastating impact on public health and welfare in Cameroon. Despite the
increasing number of studies conducted on disease prevalence, transmission patterns or …
increasing number of studies conducted on disease prevalence, transmission patterns or …
Protozoan persister-like cells and drug treatment failure
Antimicrobial treatment failure threatens our ability to control infections. In addition to
antimicrobial resistance, treatment failures are increasingly understood to derive from cells …
antimicrobial resistance, treatment failures are increasingly understood to derive from cells …
[HTML][HTML] Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Background Plasmodium vivax exacts a significant toll on health worldwide, yet few efforts to
date have quantified the extent and temporal trends of its global distribution. Given the …
date have quantified the extent and temporal trends of its global distribution. Given the …
8-Aminoquinoline therapy for latent malaria
JK Baird - Clinical Microbiology Reviews, 2019 - Am Soc Microbiol
The technical genesis and practice of 8-aminoquinoline therapy of latent malaria offer
singular scientific, clinical, and public health insights. The 8-aminoquinolines brought …
singular scientific, clinical, and public health insights. The 8-aminoquinolines brought …
Association of impaired cytochrome P450 2D6 activity genotype and phenotype with therapeutic efficacy of primaquine treatment for latent Plasmodium vivax malaria
Importance Latent hepaticPlasmodium vivaxhypnozoites provoke repeated clinical attacks
called relapses. Only primaquine phosphate kills hypnozoites, and its therapeutic activity …
called relapses. Only primaquine phosphate kills hypnozoites, and its therapeutic activity …
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
NN Chamma-Siqueira, SC Negreiros… - … England Journal of …, 2022 - Mass Medical Soc
Background In most of the Americas, the recommended treatment to prevent relapse of
Plasmodium vivax malaria is primaquine at a total dose of 3.5 mg per kilogram of body …
Plasmodium vivax malaria is primaquine at a total dose of 3.5 mg per kilogram of body …
[HTML][HTML] Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
MU Ferreira, TN de Sousa, GW Rangel… - International Journal for …, 2021 - Elsevier
Emerging antimalarial drug resistance may undermine current efforts to control and
eliminate Plasmodium vivax, the most geographically widespread yet neglected human …
eliminate Plasmodium vivax, the most geographically widespread yet neglected human …
[HTML][HTML] The global burden of Plasmodium vivax malaria is obscure and insidious
KE Battle, JK Baird - PLoS Medicine, 2021 - journals.plos.org
The global burden of Plasmodium vivax malaria is obscure and insidious | PLOS Medicine Skip
to main content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special …
to main content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special …
[HTML][HTML] Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study
Background Despite recent intensification of control measures, Plasmodium vivax poses a
major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause …
major challenge for malaria elimination efforts. Liver-stage hypnozoite parasites that cause …
[HTML][HTML] Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
J Watson, WRJ Taylor, G Bancone… - PLoS neglected …, 2018 - journals.plos.org
Background The 8-aminoquinoline antimalarials, the only drugs which prevent relapse of
vivax and ovale malaria (radical cure), cause dose-dependent oxidant haemolysis in …
vivax and ovale malaria (radical cure), cause dose-dependent oxidant haemolysis in …